our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 24 May 2016

    Antares Pharma will be attending the BIO International Convention June 6-9 in San Francisco. We look forward to meeting with you at our exhibition booth #5778!
  • 9 May 2016

    Antares Pharma Reports First Quarter 2016 Financial and Operating Results
  • 2 May 2016

    Antares Pharma to Host First Quarter Operating and Financial Results Conference Call
  • 27 April 2016

    Antares Pharma to Present at the Deutsche Bank Securities,INC. 41st Annual Healthcare Conference
  • 25 April 2016

    Otrexup.com website awarded a Bronze Horizon Interactive Award
  • 5 April 2016

    Antares Pharma Discloses "Pen 1" Development Project as Teriparatide

latest products & technology

 

Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>